0.000 0 (0%) 07-26 17:13 |
|
Open: | 0.000 |
High: | 0.000 |
Low: | 0.000 |
Pre. close: | 0.000 |
Volume: | 14,784,590 |
Avg. volume: | 2,565,697 |
MA (50): | 0.020 |
MA (200): | 37.289 |
Year high: | 35,000.000 |
Year low: | 0.000 |
Market cap: | 0(M) |
EPS: | -200 |
PE ratio: | 0 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Fri, 19 Jul 2024
Substantial Growth of Charcot Marie Tooth Disease Market - openPR
Mon, 11 Mar 2024
Pharnext takes full stock of its operating, strategic and financial situation - Actusnews
Wed, 28 Feb 2024
Pharnext progresses in analyzing data from pivotal Phase III study of PXT3003 in Charcot-Marie-Tooth disease… - Actusnews
Thu, 28 Sep 2023
Pharnext updates on the development program in China for PXT3003 in Charcot-Marie-Tooth disease type 1A… - Actusnews
Mon, 18 Sep 2023
Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, ENCell, InFlectis, Addex, Augustine, DTx Pharma - Yahoo Finance
Mon, 08 May 2023
Charcot Marie Tooth Clinical Trials 2023 (Updates): FDA - openPR
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.